Healthcare Services

Constipation treatment market overview (2026–2030)

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Constipation Treatment Market Between 2026 And 2030?

The constipation treatment market has experienced significant expansion in recent years. It is anticipated to grow from $12.71 billion in 2025 to $13.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical growth can be ascribed to a high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, continued reliance on traditional laxatives, and the increasing aging population.

The constipation treatment market size is projected to experience substantial expansion over the upcoming years, reaching a size of $18.72 billion by 2030, driven by an 8.0% compound annual growth rate (CAGR). This anticipated growth during the forecast period is fueled by several factors such as an increase in chronic constipation diagnoses, greater reliance on opioid medications, heightened public understanding of gut health, the spread of specialized gastroenterology services, and better availability of new treatments. Key developments expected in this period encompass the increasing prescription of therapies for chronic constipation, the rising popularity of probiotics and gut health items, a move towards drugs with specific mechanisms of action, a greater emphasis on managing opioid-induced constipation, and the expansion of online pharmacy channels.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Which Key Factors Are Driving The Constipation Treatment Market Growth?

The increasing prevalence of gastrointestinal disorders is anticipated to boost the expansion of the constipation treatment market in the future. These conditions, often termed digestive disorders, encompass various ailments affecting the digestive tract, with constipation being a common symptom of many gastrointestinal (GI) disorders. The rising incidence of gastrointestinal disorders, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), drives the growth of the constipation treatment market because these conditions frequently involve constipation, thereby creating a heightened necessity for specific and effective treatments amid growing public awareness. For example, in January 2024, the American Cancer Society, a US-based non-profit organization, estimated roughly 26,890 new cases of stomach cancer in the U.S. in 2024, consisting of 16,160 cases in men and 10,730 in women. This type of cancer is also expected to result in about 10,880 fatalities, involving 6,490 men and 4,390 women. Therefore, the growing occurrence of gastrointestinal disorders is propelling the constipation treatment market’s growth.

How Are Segments Identified Within The Constipation Treatment Market Segment Framework?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

Which Trends Are Guiding The Direction Of The Constipation Treatment Market?

Major companies operating in the constipation treatment market are prioritizing the development of innovative solutions, such as drug-free mechanical stimulation capsules (vibrating capsules), to meet the rising demand for effective, side-effect-sparing therapies. This demand is propelled by an aging population, increased opioid use, and patients’ inclination towards non-pharmacologic choices. A vibrating capsule represents a swallowable, single-use oral device, encompassing a small vibration motor and battery within a medical-grade, excretable shell; its purpose is to mechanically stimulate the colon at programmed times to induce peristalsis, thereby offering predictable bowel movements without the systemic effects associated with laxatives or prescription prokinetics. As an illustration, in May 2023, Vibrant Ltd., a US-based medical technology company, launched Vibrant, a prescription-only vibrating capsule system that received clearance from the U.S. Food and Drug Administration (FDA) for adults with chronic idiopathic constipation who have not responded to laxatives. The system comprises a reusable activation pod and a single-use capsule containing a coin-sized vibration motor, an electronic control card, and batteries, all encased in a two-piece shell. The pod programs the capsule, which subsequently delivers a sequence of short vibration cycles, approximately 190 cycles per hour, featuring timed bursts and rests, specifically engineered to stimulate colonic contractions.

Who Are The Companies Competing Within The Constipation Treatment Market?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Get The Full Constipation Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Where Is The Constipation Treatment Market Primarily Concentrated By Region?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Constipation Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Constipation Laxative Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-laxative-global-market-report

Opioid Induced Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795